We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique dont l'objectif est de s'attaquer aux facteurs de progression des maladies neurodégénératives et...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing new treatments for neurodegenerative and autoimmune diseases, announces that the Geneva...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the progression of neurodegenerative and autoimmune...
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 – GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Regulatory News: La société GENEURO (Paris:GNRO) et la société GILBERT DUPONT ont mis fin au contrat de liquidité conclu le 06 mars 2021. Cette résiliation a pris effet le 30 juin 2024 au soir. A...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.001 | 1.25 | 0.08 | 0.1 | 0.066 | 292922 | 0.07962439 | DE |
4 | 0.015 | 22.7272727273 | 0.066 | 0.228 | 0.0428 | 496229 | 0.11965028 | DE |
12 | -0.009 | -10 | 0.09 | 0.228 | 0.0428 | 181691 | 0.11574146 | DE |
26 | -1.614 | -95.2212389381 | 1.695 | 1.99 | 0.0428 | 139731 | 0.12648306 | DE |
52 | -0.969 | -92.2857142857 | 1.05 | 2.35 | 0.0428 | 76779 | 0.22077407 | DE |
156 | -3.519 | -97.75 | 3.6 | 4.06 | 0.0428 | 28643 | 0.43611484 | DE |
260 | -3.329 | -97.6246334311 | 3.41 | 6.28 | 0.0428 | 20534 | 0.92512037 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions